In our study, the main findings were as follows: (1) cystatin C was a powerful diagnostic indicator for cardiovascular risk factors; (2) cystatin C level was independently associated with MetS; and (3) cystatin C level was an independent predictor of MACEs during 12-month follow-up. Here, CST3 is linked to metabolic syndrome.